The κ-opioid agonist, asimadoline, alters cytokine gene expression in adjuvant arthritis

Rheumatology

Volumn 40, Issue 9, 2001, Pages 1013-1021

  Bush, K A ^a   Kirkham, B W ^b   Walker, J S ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

Adjuvant arthritis; Asimadoline; Cytokines; Inflammation; Opioids; opioid agonist

Indexed keywords

ASIMADOLINE; CYTOKINE; DRUG VEHICLE; INTERLEUKIN 17; KAPPA OPIATE RECEPTOR AGONIST; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; EXTRACTION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INGUINAL LYMPH NODE; JOINT; LYMPHOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIUM; T LYMPHOCYTE;

EID: 0034799876     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/40.9.1013     Document Type: Article

References (41)

1. Opioid peptides and opioid receptors in cells of the immune system
2. The role of endogenous opioids and their receptors in the immune system
3. Opiate analgesia. How central is a peripheral target?
4. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation
5. Peripheral analgesic actions of opioids
6. Opiates suppress carrageenan-induced oedema and hyperthermia at doses that inhibit hyperalgesia
7. The contribution of neurogenic inflammation in experimental arthritis
8. Anti-inflammatory effects of kappa-opioids in adjuvant arthritis
9. The site of anti-arthritic action of the κ-opioid, U-50,488H, in adjuvant arthritis: Importance of local administration
10. Effect of μ-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats
11. Immunomodulatory activity of μ- and κ-selective opioid agonists
12. Opioid receptor-mediated suppression of humoral immune response in vivo and in vitro: Involvement of κ opioid receptors
13. Effect of the peripherally selective κ-opioid agonist, asimadoline, on adjuvant arthritis
14. 1 antagonist GR205171
15. Inhibition of interleukin-1 and tumor necrosis factor-α synthesis following treatment of macrophages with the kappa opioid agonist U-50,488H
16. Immunopharmacology of opioids in inflammatory arthritis
17. Intercellular adhesion molecule-1 expression in adjuvant arthritis in rats: Inhibition by κ-opioid agonist but not by NSAID
18. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
19. + T cells
20. Spontaneous acceptance of rat liver allografts is associated with an early downregulation of intragraft interleukin-4 messenger RNA expression
21. CTLA-8, cloned from an activated T cell bearing AU-rich messenger RNA instability sequences, and homologous to a Herpesvirus Saimiri gene
22. Cytokine mRNA expression in adjuvant arthritis
23. Intraarticular variability of synovial membrane histology, immunohistology and cytokine mRNA expression in patients with rheumatoid arthritis
24. Cytokine gene activation in synovial membrane, regional lymph nodes, and spleen during the course of rat adjuvant arthritis
25. TNF alpha-A pivotal role in rheumatoid arthritis?
26. Interleukin-17, interferon-gamma and tumor necrosis factor mRNA is increased in adjuvant arthritis
27. The anti-inflammatory effects of opioids: Their possible relevance to the pathophysiology and treatment of rheumatoid arthritis
28. Suppression of T lymphocyte chemotactic factor production by the opioid peptides β-endorphin and met-enkephalin
29. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis
30. 14C-labelled hexadecane
31. Reevaluation of inguinal lymph node injection for production of adjuvant arthritis in the rat
32. Recruitment of lymphoblasts derived from peripheral and intestinal lymph to synovium and other tissues in normal rats and rats with adjuvant arthritis
33. Role of lymph nodes in adjuvant-induced arthritis in rats
34. Transforming growth factor β: The good, the bad and the ugly
35. Antagonistic effects of endogenous and exogenous TGF-β and TNF on auto-immune diseases in mice
36. 1 on experimental autoimmune diseases in mice
37. Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta
38. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor β
39. Cytokine therapy in rheumatoid arthritis
40. Novel developments with selective, non-peptidic kappa-opioid receptor agonists
41. Peripheral effects of the κ-opioid agonist EMD 61753 on pain and inflammation in rats and humans